Patents. Juries. Success.
Some of our wins include:
In a case involving immunoassay technology, we obtained a jury verdict of patent infringement and a permanent injunction on behalf of Abbott Laboratories.
By persuading a jury that the patents in suit were invalid, we successfully defended our client against accusations of infringement concerning a process for making fused-back automotive carpeting.
We obtained a $25 million jury verdict against industry giant Panasonic for willful infringement of our client Comair’s patents on fans for electronic equipment.
Our successful advocacy extends to patent reexaminations and interferences.
Spotlight on PatentsFor our client Dr. Leslie Stern of Fall River, Massachusetts, we recently obtained US Patent No. 8,460,310, describing a medical device for use in minimally invasive spine surgery.
In the News
We delivered a win for our client American Science and Engineering in an interference proceeding against Rapiscan Systems. More. . .
Lisa Tittemore has been selected as one of the Women Leaders in Law and will be recognized this Fall in Fortune Magazine.
Bruce Sunstein was honored to be invited, along with some of America’s foremost entrepreneurial leaders, to the President of the Republic of Korea’s “Leaders’ Meeting for a Creative Economy.”
Our Latest Thinking
- With its decision in Alice Corp., the Supreme Court persists with its ever-narrowing definition of patent-eligible subject matter. The lack of effective guidance on eligibility threatens to harm the patent system. More...
- The Supreme Court protects TV broadcasters from Aereo’s attempted end-run around the copyright laws. Despite supplying individual antennae to its customers, Aereo is found to have made impermissible “public performance” of protected content. More...
- The Supreme Court restores an old rule: Liability for inducing infringement of a patented method cannot be imposed unless a single actor performs all steps of the method. More...
- The bar has been lowered for invalidating a patent on the basis of indefiniteness. The Supreme Court says a challenger must show only that the scope of the invention is not defined with “reasonable certainty.” More...
- The FTC targets exclusive licenses in the pharmaceutical industry for antitrust scrutiny. A federal court upholds the agency’s power to do so. More...